Actively Recruiting
A Non-interventional Registry Study of Fluzoparib in the Treatment of Ovarian Cancer
Led by Tongji Hospital · Updated on 2022-01-26
490
Participants Needed
1
Research Sites
572 weeks
Total Duration
On this page
Sponsors
T
Tongji Hospital
Lead Sponsor
F
First Hospital of China Medical University
Collaborating Sponsor
AI-Summary
What this Trial Is About
Ovarian cancer is one of the most fatal malignant tumors that threaten women's health. The incidence rate is the third place among the female reproductive system malignant tumors, and the mortality rate ranks the first in gynecologic malignancies, the majority of patients have advanced diseases at the time of diagnosis. This observational study is to evaluate the safety and efficacy of fluzoparib in ovarian cancer patients under real conditions, especially in various subgroups of ovarian cancer patients, in order to provide information about treatment modes for ovarian cancer patients in real-world diagnosis and treatment, and preliminarily evaluate the pharmacoeconomic of fluzoparib in the treatment of ovarian cancer.
CONDITIONS
Official Title
A Non-interventional Registry Study of Fluzoparib in the Treatment of Ovarian Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Signed informed consent and voluntary participation
- Diagnosed by histology or cytology with epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer
- 18 years of age or older
- Investigator determines patient can receive fluzoparib monotherapy or combination therapy
- Use of effective contraception during the study and for 90 days after last fluzoparib dose for patients of childbearing potential
You will not qualify if you...
- Pregnant or lactating women
- Participation in any research involving intervention measures other than routine clinical practice
- Other situations judged by the investigator as unsuitable for study inclusion
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, China, 430030
Actively Recruiting
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here